Atlas Trials

Liver Test Study of Using JKB-122 in Hepatitis C Virus (HCV)-Positive Patients Nonresponsive to Prior Interferon Based Therapies

Clinical trial NCT02293941 · TERMINATED

Trial details

NCT number
NCT02293941
Sponsor
TaiwanJ Pharmaceuticals Co., Ltd
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2014-05-01
Primary completion
2017-08-30
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.